LATEST
Maximus Federal Services agreed to acquire Agile DefensenewMount Logan Management agreed to acquire Alternative Fund AdvisorsnewDime Commercial Bancshares / ES BancsharesnewSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESGMarwynn Holdings acquired Zhituo SoftwareAspire-Lakewood Holding acquired Dura Driver Control SystemsTransom Signal MergerSub / SoundThinkingSilgan / Trivium: minority stake
Open App
ClosedPublished 26 Sep 2023

Biogen Inc. /
Reata Pharmaceuticals, Inc.

Biogen completes merger with Reata Pharmaceuticals

Buy side: Biogen Inc.
Buy sideBiogen Inc.
Target: Reata Pharmaceuticals, Inc.
TargetReata Pharmaceuticals, Inc.
Source · 26 Sep 2023
See the source
Buy side: Biogen Inc.
Buy sideBiogen Inc.
Target: Reata Pharmaceuticals, Inc.
TargetReata Pharmaceuticals, Inc.
01 / BuyerBiogen Inc.
02 / TargetReata Pharmaceuticals, Inc.
01

What happened

Biogen Inc. completed its merger with Reata Pharmaceuticals, Inc. on September 26, 2023, with Reata surviving as a wholly owned subsidiary of Biogen.

Reata common stockholders became entitled to receive $172.50 in cash per share.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Biogen completes merger with Reata Pharmaceuticals

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.